"Estrogen" is an umbrella class of steroid hormones comprising four distinct biological molecules: Estrone (E1), 17β-Estradiol (E2), Estriol (E3), and Estetrol (E4). Among these, 17β-Estradiol (E2) is the most potent endogenous human estrogen, exhibiting roughly 80x the receptor affinity of E1 or E3. In modern menopausal hormone therapy, bioidentical transdermal 17β-estradiol has superseded older Conjugated Equine Estrogens (Premarin) by eliminating first-pass hepatic metabolism and avoiding clotting cascade activation.
In casual conversation, the words "estrogen" and "estradiol" are frequently used as if they are interchangeable.
In clinical endocrinology and pharmacology, however, estrogen is not a single hormone - it is an entire biological category of steroid molecules with vastly different receptor affinities, tissue targets, and metabolic pathways.
Furthermore, how estrogen is administered - whether as older conjugated equine compounds extracted from horses or modern bioidentical human-identical molecules delivered transdermally - completely alters its safety profile.
What are the four biological forms of human estrogen (E1, E2, E3, and E4), how does bioidentical 17$\beta$-estradiol differ from Premarin, and why is transdermal delivery the clinical gold standard?
The 4 Biological Types of Human Estrogen#
[THE HUMAN ESTROGEN HORMONE FAMILY]
│
┌──────────────────┬───────────────┴───────────────┬──────────────────┐
▼ ▼ ▼ ▼
[1. Estrone (E1)] [2. Estradiol (E2)] [3. Estriol (E3)] [4. Estetrol (E4)]
- Postmenopausal - Dominant reproductive - Dominant in - Produced solely
estrogen. years estrogen. pregnancy. by fetal liver.
- Formed in fat - MOST POTENT (10x to 80x - Weakest receptor - Natural selective
via aromatase. higher affinity than E1/E3). binding affinity. tissue profile.
| Estrogen Type | Chemical Shorthand | Primary Anatomical Site of Synthesis | Dominant Biological Phase | Relative Receptor Potency |
|---|---|---|---|---|
| 17$\beta$-Estradiol | E2 | Ovarian Granulosa Cells (via CYP19A1 aromatase conversion of testosterone). | Reproductive Years (Menarche to Perimenopause) | 100% (Baseline Reference / Highest Affinity) |
| Estrone | E1 | Peripheral Adipose Tissue & Adrenals (aromatization of androstenedione). | Postmenopause | ~10% to 12% of E2 potency |
| Estriol | E3 | Placental Syncytiotrophoblast (converted from fetal 16$\alpha$-hydroxy-DHEA-S). | Pregnancy | ~1% to 2% of E2 potency |
| Estetrol | E4 | Fetal Liver (synthesized exclusively during gestation). | Fetal Development / Pregnancy | ~5% of E2 potency |
Bioidentical 17$\beta$-Estradiol vs. Premarin (Conjugated Equine Estrogens)#
For over four decades (from the 1960s through the early 2000s), Premarin was the most commonly prescribed estrogen medication in the world.
Today, clinical societies - including The Menopause Society (NAMS) and the Endocrine Society - recommend bioidentical 17$\beta$-estradiol:
[PREMARIN (Conjugated Equine Estrogens - CEE)]
- Extracted from the urine of pregnant mares.
- Complex mixture of > 10 equine estrogens (Equilin, Equilenin, 17α-dihydroequilin).
- Foreign to human biology; tightly binds hepatic receptors.
- ORAL ROUTE ONLY: High first-pass liver impact.
VS.
[BIOIDENTICAL 17β-ESTRADIOL (Vivelle-Dot, Climara, Estrace)]
- 100% chemically identical to the estradiol synthesized by the human ovary.
- Synthesized from natural plant precursors (USP standard).
- TRANSDERMAL PATCH, GEL, OR SPRAY: Bypasses the liver entirely.
Why Transdermal Delivery Eliminates Clotting & Liver Risks#
When estrogen is swallowed in oral pill form (whether Premarin or oral estradiol), it is absorbed directly through the mesenteric veins into the portal circulation - delivering a massive, supraphysiological surge of hormone straight to the liver (the First-Pass Hepatic Effect):
[ORAL ESTROGEN (Swallowed Pill)]
│
▼
[First-Pass Hepatic Metabolism in Liver]
│
┌───────────┴───────────┐
▼ ▼
[Increases Hepatic Clotting Factors] [Increases SHBG & hs-CRP]
- Factor VII, Factor VIII, Prothrombin - Binds free testosterone.
- ELEVATES VENOUS THROMBOEMBOLISM (VTE) - Elevates inflammatory CRP.
- INCREASES BLOOD CLOT & STROKE RISK.
The Transdermal Advantage (Patches, Gels, Sprays)#
When bioidentical 17$\beta$-estradiol is applied across the skin (transdermally):
- It is absorbed directly into the systemic capillary circulation, mimicking the natural, continuous pulsatile secretion of the ovary.
- Zero first-pass hepatic metabolism: Clotting factors (Factor VII/VIII), Sex Hormone-Binding Globulin (SHBG), and High-Sensitivity C-Reactive Protein (hs-CRP) remain completely unchanged.
- Observational and clinical trial data confirm that transdermal estradiol does not increase the risk of venous thromboembolism (VTE) or ischemic stroke.
Any woman with an intact uterus who takes systemic estradiol must co-prescribe bioidentical micronized progesterone (Prometrium 100 to 200 mg) to prevent unopposed estrogen from causing endometrial hyperplasia or uterine cancer.
To explore menstrual cycle reference ranges and blood test interpretation, read Normal Estradiol Levels in Females: Blood Test Ranges & Phases.
Scientific References & Clinical Practice Guidelines#
- The NAMS 2022 Hormone Therapy Position Statement Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. doi:10.1097/GME.0000000000002028.
- Stanczyk FZ, Archer DF, Bhavnani BR. Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment. Contraception. 2013;87(6):706-727. doi:10.1016/j.contraception.2012.12.011.
- Canonico M, Oger E, Plu-Bureau G, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation. 2007;115(7):840-845. doi:10.1161/CIRCULATIONAHA.106.642280.
- Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric. 2005;8(Suppl 1):3-63. doi:10.1080/13697130500148875.
- American College of Obstetricians and Gynecologists (ACOG). Clinical Consensus No. 3: General Approaches to Medical Management of Menstrual Suppression. Obstet Gynecol. 2022;140(3):528-541.
Track Your Hormone Replacement & Lab Panels with Meridian#
Monitoring your laboratory blood biomarkers over time gives you objective validation that your diet, exercise, and lifestyle habits are keeping your metabolic health and glucose tolerance in optimal ranges.
Meridian is an offline personal health vault for iPhone designed to give you complete ownership of your medical diagnostic data.
- Instant Lab Report Extraction: Take a photo or upload a PDF of your Comprehensive Hormone Panels (Estradiol E2, Estrone E1, Progesterone, Total & Free Testosterone, DHEA-S, and SHBG) from Quest, Labcorp, or your clinic. Meridian extracts all biomarkers on-device using Apple VisionKit.
- Longitudinal Hormone Tracking: Track your transdermal estradiol dosages, symptom resolution, and serum levels over decades with total privacy.
- 100% On-Device & Private: Protected by hardware AES-256 encryption and FaceID. Zero cloud servers. Zero data tracking.
Take control of your endocrine health and medical privacy today. Download Meridian on the App Store and keep your diagnostic records organized, private, and secure.